Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares U.S. Pharmaceuticals ETF (IHE) belongs to the US Health Care segment. The Health Care Select Sector SPDR Premium Income Fund (XLVI) is part of the Options Strategies segment. Both ETFs have the same top 3 sector exposures: and Health Care. IHE is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.35% for XLVI. IHE is up 4.3% year-to-date (YTD) with +$129M in YTD flows. XLVI performs worse with 0.28% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of IHE and XLVI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE XLVI | -1.82%-1.07% | +5.93%+1.89% | +4.30%+0.28% | +28.47%n/a | +63.32%n/a | +61.21%n/a |
| Flows | IHE XLVI | +$9M+$788K | +$154M+$3M | +$129M+$2M | +$248M- | +$359M- | +$393M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE XLVI | +15.86%+10.15% | +20.40%n/a | +15.94%n/a | +15.80%n/a |
| Max drawdown | IHE XLVI | -4.49%-3.26% | -14.18%n/a | -16.04%n/a | -16.12%n/a |
| Max drawdown duration | IHE XLVI | 10d10d | 150dn/a | 210dn/a | 669dn/a |
IHE | XLVI | |
Last sale 3/12/2026 at 1:30 PM | $86.66 | $25.54 |
| Previous close 03/11/2026 | $88.40 | $25.92 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHE | XLVI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHE | XLVI | |
|---|---|---|
| Last price | $86.66 | $25.54 |
| 1D performance | -1.97% | -1.47% |
| AuM | $1.02 B | $13.24 M |
| E/R | 0.38% | 0.35% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.